Abstract
Many antimicrobial peptides are considered to kill microbes by permeabilizing cell membranes. This chapter summarizes the driving force of peptide binding to membranes; various mechanisms of lipid bilayer permeabilization including the barrel-stave, toroidal pore, and carpet models; and modes of permeabilization of bacterial and mammalian membranes.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Membrane permeabilization
- Membrane binding
- Membrane curvature
- Barrel-stave model
- Toroidal pore model
- Carpet model
1 Introduction
Membrane permeabilization as a mechanism for bacterial killing has already been suggested in a paper on the discovery of magainins from the African clawed frog Xenopus laevis, an archetypical antimicrobial peptide (AMP) isolated from a vertebrate for the first time (Zasloff 1987). As shown in Fig. 2.1, the addition of magainin 2 to E. coli cells induced an efflux of intracellular K+ ions and concomitantly a decrease in cell viability in minutes (Matsuzaki et al. 1997a). Rapid killing is an important self-defense action of AMPs. Observations that enantiomeric peptides composed of all D-amino acids are equipotent to the parent L-peptides indicate that proteins requiring chiral recognition such as receptors and enzymes are not involved in the membrane permeabilization process (Bessalle et al. 1990; Wade et al. 1990). Furthermore, magainins induce the leakage of water-soluble dyes entrapped in artificial lipid vesicles (Matsuzaki et al. 1989, 1991a), suggesting that the lipid matrix of membranes is a target of the peptides. Many AMPs such as tachyplesin I (Matsuzaki et al. 1991b) and LL-37 (Lee et al. 2011) also permeabilize membranes.
2 Membrane Binding
The first step in the membrane permeabilization process is the binding of peptides to membranes. AMPs are generally polycationic and amphipathic. In many cases, linear peptides take unordered structures in an aqueous solution, whereas they are conformed to be amphipathic secondary structures, typically α-helices or β-strands, upon membrane binding (Matsuzaki et al. 1989, 1991a). Such amphipathic structures fit the membrane–water interface. Even conformationally restricted cyclic peptides also change their structures to accommodate themselves to membrane environments (Imura et al. 2007).
The main driving forces for membrane binding are electrostatic attraction and hydrophobic interaction (Matsuzaki et al. 1995a, 2009). Positively charged peptides preferentially interact with negatively charged membranes. Bacterial membranes are rich in acidic phospholipids (phosphatidylglycerol and cardiolipin ). Furthermore, cell walls containing lipopolysaccharide s (LPS ) and peptidoglycan s are also negatively charged. In contrast, mammalian cell membranes are less negatively charged. Acidic phospholipids, such as phosphatidylserine , are essentially sequestered on the cytoplasmic face of the membrane, although cancer cells show an increased exposure of phosphatidylserine (Utsugi et al. 1991). However, ganglioside s containing sialic acid residues have some negative charges on the cell surface, which are a target of AMPs (Miyazaki et al. 2012). Interestingly, acidic phospholipids and gangliosides interact differently with AMPs (Fig. 2.2). Cationic peptides specifically bind to gangliosides containing anionic sialic acid residues so that the charge is neutralized. The binding is described by the Langmuir-type equation. Fluorescent resonance transfer experiments clearly revealed that AMPs preferentially interacted with monosialoganglioside GM1 compared with phosphatidylcholine in a GM1/phosphatidylcholine mixed bilayer mimicking mammalian cell membranes. In contrast, peptides equally interact with anionic phosphatidylglycerol and zwitterionic phosphatidylcholine in a phosphatidylglycerol/phosphatidylcholine mixed membrane, a model for bacterial cell membranes (Miyazaki et al. 2012). The interaction is theoretically explained by a combination of the Gouy-Chapman theory (electrostatic concentration immediately above the membrane surface) and a partition equilibrium (Wenk and Seelig 1998; Wieprecht et al. 1999).
3 Permeabilization of Model Membranes
Membrane-bound AMPs change membrane structures and organizations leading to membrane permeabilization. Using model membranes such as liposomes, several mechanisms so far proposed for this can be roughly classified into two categories, i.e., membrane curvature modulation and phase separation. The recently proposed latter mechanism includes clustering of acidic lipids by cationic AMPs and is described in Chap. 5. The “barrel-stave channel,” “toroidal pore,” and original “carpet” mechanisms are categorized as the former mechanism (Fig. 2.3). Refer to Chap. 3 and a review by Huang (2006) for theoretical treatments.
Amphipathic secondary structures on the surface of membranes can modulate membrane curvature. The peptides expand the interfacial region, making a void in the hydrocarbon region of the membrane. Consequently, membrane-thinning and positive curvature (concave) strain are induced (Fig. 2.3a left). At threshold peptide-to-lipid ratios, typically below ~1:100, the surface-lying peptides are cooperatively inserted into the membrane, forming a water-filled pore (Fig. 2.3a right). Peptaibol s, peptides containing Aib (aminoisobutyric acid) residues with the C-terminal alcohol, have been known to form a barrel-stave channel (Sansom 1991). These peptides are electrostatically almost neutral. A typical example is the antibiotic alamethicin produced by the fungus Trichoderma viride. The channel is solely composed of helical peptides. The ionic current is discrete and the conductance depends on the number of peptides involved in a single channel. Magainins were also considered to form this type of channel at the time of its discovery. However, we noticed that this was not the case and proposed the toroidal pore model in 1996 (Matsuzaki et al. 1996a).
First, in the case of the barrel-stave channel, the size of the pore depends on the peptide-to-lipid molar ratio. However, as shown in Fig. 2.4, the small I− ion and the medium-sized calcein dye leaked out of liposomes in the same range of peptide-to-lipid ratio, and larger dye-labeled dextran molecules were retained even at higher peptide-to-lipid ratios, suggesting that a pore of defined size (diameter 2–3 nm) was formed.
Second, the leakage kinetics were unique. The percent leakage value appeared to reach a plateau instead of complete leakage, indicating that the number of pores decreased with increasing time (Fig. 2.5). We hypothesized that pores were unstable and a fraction of peptide molecules was translocated into the inner leaflet. Thus, the peptide density in the outer leaflet decreased, decelerating pore formation. Indeed, the translocation was coupled to the leakage. Kinetic analysis suggested that a pore is composed of ~5 magainin molecules, which appeared to be too small to allow the passage of calcein (Matsuzaki et al. 1995b). Thus, we hypothesized that lipid molecules were also involved in the pore structure and examined the flip–flop of lipids. The flop was again coupled to leakage and translocation (Fig. 2.5). The flip rate was identical to the flop rate and did not depend on the type of lipid, suggesting that all lipid molecules in the membrane were randomized (Matsuzaki et al. 1996a). Based on these observations, we proposed the toroidal pore model, in which both the polar faces of the amphiphilic helices and the polar headgroups of lipids constitute the pore wall. This unique structure allows not only the passage of ions and small molecules through the pore but also the rapid flip–flop of lipids along the pore wall. Both types of events seem to contribute to bactericidal activity. The flop of phosphatidylserine was also observed in mammalian cells (Imura et al. 2008). The structure of the toroidal pore was confirmed by neutron scattering experiments by Huang’s group (Ludtke et al. 1996).
Not only magainins but also other AMPs and membrane-acting peptides form toroidal pores, including helical PGLa (Matsuzaki et al. 1998a), mastoparan X (Matsuzaki et al. 1996b), melittin (Yang et al. 2001), buforin 2 (Kobayashi et al. 2004), and cyclic β-sheet tachyplesin I (Imura et al. 1768). The pore size depends on the type of peptide. The two substitutions F5Y and F16W for magainin 2 enlarged the pore size to 4–7 nm (Hara et al. 2001). The bacteriocin lacticin Q also forms a large toroidal pore of similar size (Yoneyama et al. 2009).
The mode of dye leakage is classified into an all-or-none or graded mode . In the former, some vesicles are empty, whereas the rest are intact. In the latter, all vesicles partially lose their contents. Although these modes are sometimes considered to originate from different leakage mechanisms, earlier theoretical studies showed that the pore lifetime τ determines the mode of leakage (Schwarz and Arbuzova 1995; Schwarz and Robert 1992). The all-or-none and the graded mode correspond to τ >> τ 0 (the time necessary for a 1/e reduction in the intravesicular dye concentration) and τ << τ 0, respectively.
The pore lifetime is governed by electrostatics within the pore and is therefore modulated by both peptide charge and lipid composition because the toroidal pore is composed of peptides and lipids. An increase in peptide positive charge destabilizes the pore because of enhanced electrostatic repulsion between closely spaced peptides, facilitating peptide translocation (Matsuzaki et al. 1997b). Note that translocation occurs only upon the disintegration of the pore. For example, an increase in the positive charge of magainin from +4 to +6 reduced the τ value from 9τ 0 to 0.1τ 0. Buforin 2 with +6 charges is translocated across liposomal (Kobayashi et al. 2000) and bacterial (Park et al. 1998) membranes without permeabilizing them. Similarly, an increase in acidic lipid content stabilizes the pore by reducing electrostatic repulsion between peptides in a pore (Kobayashi et al. 2004). Dye leakage and lipid flip–flop are observed in this case.
Another well-known mechanism of membrane permeabilization is the original “carpet model,” in which peptides cover the membrane surface like a carpet and disrupt the bilayer organization (Shai 1995) (Fig. 2.3b). This model was proposed following studies on the interaction between cecropins and dermaseptins with phosphatidylserine-containing bilayers. We found that even magainins do not form toroidal pores, but accumulate on the membrane surface and eventually disrupt it at peptide-to-lipid ratios above 1:10 in membranes containing phosphatidylserine (Fig. 2.6), phosphatidic acid, or cardiolipin (Matsuzaki et al. 1998b). These lipids form hexagonal-II phases under charge-neutralizing conditions and thus tend to induce negative curvature strain on the membrane, counteracting the positive curvature strain imposed by magainins and allowing accumulation of huge amounts of peptides on the membrane. Thus, the mechanism of membrane permeabilization is not unique to peptides, but also depends on the physicochemical properties of membranes. It should be noted that the current modified carpet model also includes toroidal pore formation (Oren and Shai 1998), although its scientific validity needs careful consideration. Recently, the detergent-like model (Bechinger and Lohner 2006) and the interfacial activity model (Wimley 2010) have been proposed for the mechanism of AMPs. These more comprehensive models are similar to the curvature modulation mechanism described above in that the incorporation of amphipathic structures in lipid bilayers modifies the bilayer organization.
4 Permeabilization of Bacterial Membranes
AMPs have been proposed to disrupt and permeabilize the outer membrane of Gram-negative bacteria by the “self-promoted pathway ” (Hancock and Chapple 1999). Cationic peptides compete with Mg2+ ions that bridge between adjacent phosphates of LPS. Magainin forms a helix upon binding to the lipid A moiety of LPS (Matsuzaki et al. 1999) and induces blebs on the outer membrane, while the presence of Mg2+ ions inhibits its antimicrobial activity (Matsuzaki et al. 1997a). The permeabilization of the outer membrane can be detected by the permeation of impermeable substances such as nonionic detergents (Matsuzaki et al. 1997a) and 1-N-phenylnaphthylamine (NPN ) (Zhang et al. 1999). Recently, a method based on the leakage of green fluorescent protein (GFP ) expressed in the periplasmic space was developed (Sochacki et al. 2011). Note that the diameter of the protein (4.5 nm) is larger than that of the magainin toroidal pore (2–3 nm).
The permeabilization of cytoplasmic membranes can be monitored by several techniques. The efflux of intracellular K+ ions is detected by a K+-selective electrode (Matsuzaki et al. 1997a). Potential sensitive dyes, such as diSC35 , detect the dissipation of transmembrane potential (Patrzykat et al. 2002). The hydrolysis of o-nitrophenyl-β-D-galactoside (ONPG ) by cytoplasmic β-galactosidase is also often utilized for E. coli ML-35 (lacI −, lacY −, lacZ +). More convenient methods include observation of the cell entry of water-soluble dyes such as calcein (Imura et al. 2008) and Sytox Green (Sochacki et al. 2011) by fluorescent microscopy.
Which mechanism works better for the interaction of AMPs with bacterial membranes is a matter of attention (Wimley 2010; Roversi et al. 2014). Generally, the amount of peptide bound to bacterial cells at its minimum inhibitory or bactericidal concentration (MIC or MBC) is considered. However, it should be noted that MIC or MBC is the concentration needed to inhibit the growth of or to kill the most resistant population of bacteria and is thus too strong for the other more susceptible populations. The experimental conditions in Fig. 2.1 may be appropriate for discussion because about 50% of bacteria are killed. Assuming that (1) peptide molecules are intact and completely bound to both leaflets of the outer and inner membranes, (2) the binding to other bacterial components is negligible, and (3) the number of lipids per cell is 4 × 107 (Roversi et al. 2014), the peptide-to-lipid ratio in the inner membrane is ~1. To examine the direct interaction of magainin 2 with inner membranes, we used E. coli spheroplasts lacking outer membranes (Matsuzaki et al. 1997a). The peptide lysed spheroplasts in a peptide-to-lipid ratio range of 0.1–1, in accordance with the rough estimate above. The lipid composition of the spheroplasts was 68% phosphatidylethenolamine /24% phosphatidylglycerol/8% cardiolipin. Asymmetry of lipid distribution in the inner membrane has not yet been observed (Furse and Scott 2016). Nevertheless, even if the inner leaflet is composed of phosphatidylethenolamine alone, the outer leaflet is composed of ~50% phosphatidylglycerol and ~50% lipids with a negative-curvature tendency (cardiolipin and phosphatidylethenolamine). Thus, the original carpet mechanism is more likely, although further studies are needed to confirm this. Transmission electron microscopy revealed that LL-37 caused local perturbations and breaks along P. aeruginosa cell membranes (Andersson et al. 2004). However, the mechanism of membrane permeabilization may depend on the type of AMPs, as well as bacterial strains. Magainin appears to form a toroidal pore against the Gram-positive B. megaterium because the peptide forms membrane lesions of definite size (~2.8 nm, <6.6 nm) (Imura et al. 2008).
5 Permeabilization of Mammalian Cell Membranes
Relatively little is known about how AMPs permeabilize and are translocated across mammalian cell membranes. Our earlier work suggested that prototypical membrane-permeabilizing magainin 2 and intracellular-targeting buforin 2 interact with human cells differently (Takeshima et al. 2003). Dye-labeled magainin was translocated across HeLa cells via both energy-dependent and energy-independent mechanisms, and the internalization was accompanied by cytotoxicity. In contrast, dye-labeled buforin penetrates cells in an energy-independent fashion and exerts little toxicity. Zanetti’s group reported that the Pro-rich peptide Bac7 (1–35) is taken up by murine and human cells through a nontoxic energy- and temperature-dependent process (Tomasinsig et al. 2006). Details on so-called cell-penetrating peptide (CPP) are described in Chap. 7.
6 Conclusion
Thirty years of extensive studies, both experimental and theoretical, have revealed several basic mechanisms for the permeabilization of lipid bilayers by AMPs, as described above. It depends on both peptide sequences and lipid compositions. However, the molecular details are difficult to understand because initial membrane permeabilization is often dynamic and transient in nature, whereas spectroscopic methods usually detect equilibrium states after the permeabilization ceases. In contrast to model membrane studies, little is known on the permeabilization mechanisms of bacterial and mammalian cells, which remain subjects of further study.
References
Andersson E, Rydengard V, Sonesson A, Morgelin M, Bjorck L, Schmidtchen A (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271:1219–1226
Bechinger B, Lohner K (2006) Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta 1758:1529–1539
Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M (1990) All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274:151–155
Furse S, Scott DJ (2016) Three-dimensional distribution of phospholipids in gram negative bacteria. Biochemistry 55:4742–4747
Hancock REW, Chapple DS (1999) Peptide antibiotics. Antimicrob Agents Chemother 43:1317–1323
Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T et al (2001) Effect of peptide dimerization on pore formation: antiparallel disulfide-dimerized magainin 2 analog. Biopolymers 58:437–446
Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758:1292–1302
Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K (2007) Action mechanism of tachyplesin I and effects of PEGylation. Biochim Biophys Acta 1768:1160–1169
Imura Y, Choda N, Matsuzaki K (2008) Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells. Biophys J 95:5757–5765
Kobayashi S, Takeshima K, Park CB, Kim SC, Matsuzaki K (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39:8648–8654
Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y et al (2004) Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 43:15610–15616
Lee C-C, Sun Y, Qian S, Huang HW (2011) Transmembrane pores formed by human antimicrobial peptide LL-37. Biophys J 100:1688–1696
Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW (1996) Membrane pores induced by magainin. Biochemistry 35:13723–13728
Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788:1687–1692
Matsuzaki K, Harada M, Handa T, Funakoshi S, Fujii N, Yajima H et al (1989) Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim Biophys Acta 981:130–134
Matsuzaki K, Harada M, Funakoshi S, Fujii N, Miyajima K (1991a) Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta 1063:162–170
Matsuzaki K, Fukui M, Fujii N, Miyajima K (1991b) Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes. Biochim Biophys Acta 1070:259–264
Matsuzaki K, Sugishita K, Fujii N, Miyajima K (1995a) Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34:3423–3429
Matsuzaki K, Murase O, Miyajima K (1995b) Kinetics of pore formation induced by an antimicrobial peptide, magainin 2. Biochemistry 34:12553–12559
Matsuzaki K, Murase O, Fujii N, Miyajima K (1996a) An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35:11361–11368
Matsuzaki K, Yoneyama S, Murase O, Miyajima K (1996b) Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry 35:8450–8456
Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K (1997a) Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of gram-negative bacteria. Biochim Biophys Acta 1327:119–130
Matsuzaki K, Nakamura A, Murase O, Sugishita K, Fujii N, Miyajima K (1997b) Modulation of magainin 2–lipid bilayer interactions by peptide charge. Biochemistry 36:2104–2111
Matsuzaki K, Mitani Y, Akada K, Murase O, Yoneyama S, Zasloff M et al (1998a) Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 37:15144–15153
Matsuzaki K, Sugishita K, Ishibe N, Ueha M, Nakata S, Miyajima K et al (1998b) Relationship of membrane curvature to the formation of pores by magainin. Biochemistry 37:11856–11863
Matsuzaki K, Sugishita K, Miyajima K (1999) Interactions of an antimicrobial peptide, magainin 2 with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett 449:221–224
Miyazaki Y, Aoki M, Yano Y, Matsuzaki K (2012) Interaction of antimicrobial peptide magainin 2 with gangliosides as a target for human cell binding. Biochemistry 51:10229–10235
Oren Z, Shai Y (1998) Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47:451–463
Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257
Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RE (2002) Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 46:605–614
Roversi D, Luca V, Aureli S, Park Y, Mangoni ML, Stella L (2014) How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23. ACS Chem Biol 9:2003–2007
Sansom MSP (1991) The biophysics of peptide models of ion channels. Prog Biophys Mol Biol 55:139–235
Schwarz G, Arbuzova A (1995) Pore kinetics reflected in the dequenching of a lipid vesicle entrapped fluorescent dye. Biochim Biophys Acta 1239:51–57
Schwarz G, Robert CH (1992) Kinetics of pore-mediated release of marker molecules from liposomes or cells. Biophys Chem 42:291–296
Shai Y (1995) Molecular recognition between membrane-spanning polypeptides. Trends Biol Sci 20:460–465
Sochacki KA, Barns KJ, Bucki R, Weisshaar JC (2011) Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc Natl Acad Sci U S A 108:E77–E81
Takeshima K, Chikushi A, Lee K-K, Yonehara S, Matsuzaki K (2003) Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 278:1310–1315
Tomasinsig L, Skerlavaj B, Papo N, Giabbai B, Shai Y, Zanetti M (2006) Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem 281:383–391
Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51:3062–3066
Wade D, Boman A, Wåhlin B, Drain CM, Andreu D, Boman HG et al (1990) All-D amino acid-containing channel forming antibiotic peptides. Proc Natl Acad Sci U S A 87:4761–4765
Wenk MR, Seelig J (1998) Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry 37:3909–3916
Wieprecht T, Beyermann M, Seelig J (1999) Binding of antibacterial magainin peptides to electrically neutral membranes: thermodynamics and structure. Biochemistry 38:10377–10387
Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905–917
Yang L, Harroun TA, Weiss TM, Ding L, Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81:1475–1485
Yoneyama F, Imura Y, Ohno K, Zendo T, Nakayama J, Matsuzaki K et al (2009) Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob Agents Chemother 53:3211–3217
Zasloff M (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84:5449–5453
Zhang L, Benz R, Hancock REW (1999) Influence of proline residues on the antibacterial and synergistic activities of α-helical peptides. Biochemistry 38:8102–8111
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Matsuzaki, K. (2019). Membrane Permeabilization Mechanisms. In: Matsuzaki, K. (eds) Antimicrobial Peptides. Advances in Experimental Medicine and Biology, vol 1117. Springer, Singapore. https://doi.org/10.1007/978-981-13-3588-4_2
Download citation
DOI: https://doi.org/10.1007/978-981-13-3588-4_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3587-7
Online ISBN: 978-981-13-3588-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)